Categories: HealthcareNews

Therap Services Unveils New Drug Count Module to Streamline Medications Management and Tracking in Healthcare Settings

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TORRINGTON, Conn., June 25, 2024 /PRNewswire/ — Therap Services, the leading provider of electronic health record and documentation solutions for organizations and caregivers in the Long-Term Services and Supports (LTSS), Home and Community-Based Services (HCBS), and other human services industries, proudly announces the launch of its innovative Drug Count module. This new feature is designed to enhance the processes involved in tracking and managing medications and keeping counts of drug usage for individuals under care across various healthcare settings.

Users assigned with the Medication History Count role will have a new Drug Count option in the ‘Medication History’ section within the Therap system. Users with this role will be able to add new drug counts and search through the existing recorded drug counts. This role is crucial for users who need to manage and execute drug counts, allowing for precise monitoring and management of accurate medication inventories.

The Drug Count module has the ability to select from various record types — such as Log, Refill, Wasted, Destroyed, and Returned — which provides users with comprehensive options for detailed medication tracking. Additionally, the module is equipped with a Time Zone field that adjusts the count date and time based on the time zone of the selected Medication History form, ensuring consistency and accuracy in record-keeping across different locations.

Security and control are paramount in the Drug Count module. Once a drug count form is saved, it remains in an Approved status within the system, and users can generate a PDF of the form for secure record-keeping. The module also integrates seamlessly with both the Medication History form and the Medication Administration Record (MAR) module, allowing for efficient navigation and use across different system interfaces.

Therap’s commitment to providing innovative, user-friendly solutions is evident in the Drug Count module. By simplifying the drug count process, the module not only enhances operational efficiency but also ensures compliance with health standards, improving the safety and effectiveness of medication administration.

For more information on Therap’s Comprehensive Electronic Health Records for Service Providers, please visit: https://www.therapservices.net/products/comprehensive-electronic-health-records-for-service-providers/

About Therap

Therap’s comprehensive and HIPAA-compliant software is used in human services settings for documentation, communication, reporting, EVV and billing.

Learn more at www.therapservices.net.

Related Links
http://www.therapservices.net 

View original content:https://www.prnewswire.com/news-releases/therap-services-unveils-new-drug-count-module-to-streamline-medications-management-and-tracking-in-healthcare-settings-302181970.html

SOURCE Therap Services

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

11 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

11 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

11 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

11 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

11 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

11 hours ago